Social Starts — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
AmplifiDx develops point-of-care molecular diagnostic tests and its DX 100 platform for family, women's, and sexual health, targeting infectious disease detection for healthcare professionals and patients.
BiotechDigital HealthFemTechHealthtechMedical DevicesPleasanton, US
Nancy Schoenbrunner(Chief Executive Officer)Shoulian Dong(Chief Scientific Officer)Daniel Schoener(Chief Product Officer)Chris Meda(Chief Commercial Officer)Ming Tan(Director)Sammy Datwani(Director)
Co-investorsBeacon AngelsShepherd Ventures
Edifice Health offers the Inflammatory Age test, a biomarker composite scoring system that measures and monitors a person's inflammatory and immune health for early detection and prevention of chronic disease.
AI & Machine LearningBiotechDigital HealthHealthtechLongevitySan Mateo, US
David Furman, PhD(Co-Founder & Chairman of the Scientific Advisory Board)Mark Davis, PhD(Co-Founder & Scientific Advisory Board Member)inWolfgang Daum(Executive Officer, Director)David Goldberg(CEO)inDavid Furman(Director)
BoardNaveen Krishnan(Director)
Co-investorsBetter Food VenturesJoyance PartnersPaladin Capital GroupAhren Innovation CapitalLeaps by Bayer
Wellness & FitnessNew York City, US
Aaron Albert(Executive Officer, Director)Mark Groves(Executive Officer)Matthew Sadofsky(Director)
BoardJeff Cantalupo(Director)
Co-investorsTechstarsAble PartnersJoyance PartnersListen VenturesRoute 66 VenturesWndrCo
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.